Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen

This publication has 21 references indexed in Scilit:

• Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, following Oral Administration of Single Doses to HIV-Infected Adults
  Antimicrobial Agents and Chemotherapy, 1999
• Indinavir-based treatment of HIV-1 infected patients: efficacy in the central nervous system
  AIDS, 1999
• Determination of Indinavir, A HIV-1 Protease Inhibitor, in Human Plasma Using Ion-pair Reversed-phase High-Performance Liquid Chromatography
  Therapeutic Drug Monitoring, 1999
• Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1999
• Failure to Detect Nelfinavir in the Cerebrospinal Fluid of HIV-1-Infected Patients With and Without AIDS Dementia Complex
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
• Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor
  Pharmaceutical Research, 1999
• Analysis of ritonavir in plasma/serum and tissues by high-performance liquid chromatography
  Journal of Pharmacological and Toxicological Methods, 1998
• High-performance liquid chromatographic determination of ritonavir in human plasma, cerebrospinal fluid and saliva
  Journal of Chromatography B: Biomedical Sciences and Applications, 1998
• Amprenavir
  Drugs, 1998
• Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1997